Goldman Sachs Raises PT on Cepheid to $46

Symbols: CPHD
Share

Goldman Sachs has raised the price target on Cepheid (NASDAQ: CPHD) from $45 to $46 and maintains its Buy rating.


 
 
< Previous
Citigroup Raises PT on Baxter International to $51
Next >
UPDATE: Jeffries Lowers PT to $43 on Altera
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust